Building the Future Therapies for down Syndrome: The Third International Conference of the T21 Research Society

Mara Dierssen, Yann Herault, Pablo Helguera, Maria Martínez De Lagran, Anna Vazquez, Bradley Christian, Maria Carmona-Iragui, Frances Wiseman, William Mobley, Elizabeth M.C. Fisher, Veronique Brault, Anna Esbensen, Lisa M. Jacola, Marie Claude Potier, Eric D. Hamlett, Leonard Abbeduto, Laura Del Hoyo Soriano, Jorge Busciglio, Maria Florencia Iulita, John CrispinoSébastien Malinge, Eugenio Barone, Marzia Perluigi, Floriana Costanzo, Jean Maurice Delabar, Renata Bartesaghi, Alain D. Dekker, Peter De Deyn, Juan Fortea Ormaechea, Patricia A. Shaw, Tarik F. Haydar, Stephanie L. Sherman, André Strydom, Anita Bhattacharyya

Research output: Contribution to journalArticlepeer-review


Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6-9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer's disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and phar-ma-cological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21.

Original languageEnglish (US)
JournalMolecular Syndromology
StateAccepted/In press - 2021
Externally publishedYes


  • Alzheimer's disease
  • Biomarkers
  • Down syndrome
  • Intellectual disability
  • Language impairment
  • Mouse models
  • Neurodevelopmental disorders
  • Trisomy 21 Research Society

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Building the Future Therapies for down Syndrome: The Third International Conference of the T21 Research Society'. Together they form a unique fingerprint.

Cite this